Safety , efficacy , and pharmacokinetics / pharmacodynamics of daclizumab ( anti-CD 25 ) in patients with adult T-cell leukemia / lymphoma
暂无分享,去创建一个
Thomas | Urquhart | E. Jaffe | M. Turner | J. Shih | W. Figg | J. Janik | C. Goldman | C. Peer | T. Fleisher | D. Stewart | A. Waldmann | G. Wharfe | E. Nicole | J. Morris | J. Berkowitz | Stetler-Stevenson | Maryalice | J. Morris